V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
E
ELVNAI Stock Diagnostic Report

Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock

The news that Enliven Therapeutics' Chief Medical Officer sold approximately $13,000 worth of ELVN stock is assessed as a neutral internal transaction with limited impact.

View Source Article ↗
AI CATALYST SCORE30 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

ELVN Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-21 22:28:36ELVN30RowView Report →
2026-10-08 11:52:11ELVN50MidView Report →
2026-10-07 03:19:36ELVN75MidView Report →
View Full History for ELVN (Blueprint) →